Printer Friendly

CEPHALON NAMES DIRECTOR OF BUSINESS DEVELOPMENT

 CEPHALON NAMES DIRECTOR OF BUSINESS DEVELOPMENT
 WEST CHESTER, Penn., Jan. 27 /PRNewswire/ -- Cephalon, Inc.


(NASDAQ: CEPH) announced that Nicholas Landekic has joined the company as director of business development. The announcement was made today by Jack Lief, vice president of corporate development for Cephalon, Inc.
 Nick joins Cephalon from Bristol-Myers Squibb Corporation where he was senior manager, business planning, worldwide strategic management, specializing in CNS (Central Nervous System). Prior to Bristol-Myers Squibb, Nick spent four years with the McNeil Pharmaceutical Division of Johnson & Johnson, most recently as manager, new business development.
 "We are pleased to have Nick join corporate development at Cephalon," stated Jack Lief. "Nick brings with him valuable expertise in the evaluation of licensing opportunities, markets, and new business development. These skills will be increasingly important as Cephalon moves more of its lead compounds from research through clinical trials and into marketing."
 Cephalon was founded in 1987 to discover, develop and commercialize novel therapeutic products for the treatment of stroke and neurodegenerative disorders including ALS and Alzheimer's disease.
 -0- 1/27/92
 /CONTACT: Nicole Vitullo of Cephalon, 215-344-0200/
 (CEPH) CO: Cephalon, Inc. ST: Pennsylvania IN: MTC SU: PER


JT -- NY012 -- 3519 01/27/92 08:01 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 27, 1992
Words:199
Previous Article:CAREER ELI LILLY EXECUTIVE, E. WALTER LANGE, ELECTED TO LASERSCOPE BOARD OF DIRECTORS
Next Article:ARTHUR ANDERSEN'S IVAN FAGGEN PREDICTS APARTMENTS ARE BEST REAL ESTATE BET OF THE DECADE
Topics:


Related Articles
CEPHALON APPOINTS NEW SCIENCE ADVISORY BOARD MEMBER
CEPHALON NAMES VICE PRESIDENT OF DRUG DEVELOPMENT
CEPHALON APPOINTS DIRECTOR OF MEDICAL AFFAIRS
CEPHALON, INC. APPOINTS MARTYN D. GREENACRE TO NEW BOARD SEAT
CEPHALON APPOINTS VICE PRESIDENT, WORLDWIDE CLINICAL RESEARCH
CEPHALON APPOINTS JOSEPH DAY SENIOR VICE PRESIDENT, WORLDWIDE CORPORATE DEVELOPMENT
CEPHALON EXPANDS DRUG DEVELOPMENT GROUP
CEPHALON APPOINTS ROBERT ROCHE VICE PRESIDENT, SALES AND MARKETING
CEPHALON APPOINTS GRANEY VICE PRESIDENT, CLINICAL OPERATIONS
CEPHALON APPOINTS COLIN MARKLAND MEDICAL DIRECTOR, EUROPE

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters